CureVac (NASDAQ:CVAC) just reported results for the second quarter of 2024.
- CureVac reported earnings per share of -32 cents. This was below the analyst estimate for EPS of -29 cents.
- The company reported revenue of $8.16 million.
- This was 37.37% better than the analyst estimate for revenue of $5.94 million.